30 related articles for article (PubMed ID: 26951009)
1. Construction and characterization of recombinant senecavirus A expressing secreted luciferase for antiviral screening.
Wang H; Mo Y; Liu W; He Q; Ren T; Ouyang K; Chen Y; Huang W; Wei Z
J Virol Methods; 2024 Jun; 327():114932. PubMed ID: 38582378
[TBL] [Abstract][Full Text] [Related]
2. Quantitative High-Throughput Screening Using a Coincidence Reporter Biocircuit.
Schuck BW; MacArthur R; Inglese J
Curr Protoc Neurosci; 2017 Apr; 79():5.32.1-5.32.27. PubMed ID: 28398644
[TBL] [Abstract][Full Text] [Related]
3. Semi-Automated High-Throughput Substrate Screening Assay for Nucleoside Kinases.
Hellendahl KF; Fehlau M; Hans S; Neubauer P; Kurreck A
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768989
[TBL] [Abstract][Full Text] [Related]
4. Metal organic framework encapsulated tamavidin-Gluc reporter: application in COVID-19 spike antigen bioluminescent immunoassay.
Reyes S; Rizzo E; Ting A; Dikici E; Daunert S; Deo SK
Sens Diagn; 2022 Nov; 1(6):1198-1208. PubMed ID: 36561132
[TBL] [Abstract][Full Text] [Related]
5. An RNA trapping mechanism in Alphavirus mRNA promotes ribosome stalling and translation initiation.
Toribio R; Díaz-López I; Boskovic J; Ventoso I
Nucleic Acids Res; 2016 May; 44(9):4368-80. PubMed ID: 26984530
[TBL] [Abstract][Full Text] [Related]
6. Screening methods for influenza antiviral drug discovery.
Atkins C; Evans CW; White EL; Noah JW
Expert Opin Drug Discov; 2012 May; 7(5):429-38. PubMed ID: 22435452
[TBL] [Abstract][Full Text] [Related]
7. Development and characterization of a stable luciferase dengue virus for high-throughput screening.
Zou G; Xu HY; Qing M; Wang QY; Shi PY
Antiviral Res; 2011 Jul; 91(1):11-9. PubMed ID: 21575658
[TBL] [Abstract][Full Text] [Related]
8. Validation of a cell-based ELISA as a screening tool identifying anti-alphavirus small-molecule inhibitors.
Spurgers KB; Hurt CR; Cohen JW; Eccelston LT; Lind CM; Lingappa VR; Glass PJ
J Virol Methods; 2013 Oct; 193(1):226-31. PubMed ID: 23764417
[TBL] [Abstract][Full Text] [Related]
9. A high throughput antiviral screening platform for alphaviruses based on Semliki Forest virus expressing eGFP reporter gene.
Shi YJ; Li JQ; Zhang HQ; Deng CL; Zhu QX; Zhang B; Li XD
Virol Sin; 2023 Aug; 38(4):585-594. PubMed ID: 37390870
[TBL] [Abstract][Full Text] [Related]
10. Repurposed FDA-Approved drug sorafenib reduces replication of Venezuelan equine encephalitis virus and other alphaviruses.
Lundberg L; Brahms A; Hooper I; Carey B; Lin SC; Dahal B; Narayanan A; Kehn-Hall K
Antiviral Res; 2018 Sep; 157():57-67. PubMed ID: 29981794
[TBL] [Abstract][Full Text] [Related]
11. High-throughput, luciferase-based reverse genetics systems for identifying inhibitors of Marburg and Ebola viruses.
Uebelhoer LS; Albariño CG; McMullan LK; Chakrabarti AK; Vincent JP; Nichol ST; Towner JS
Antiviral Res; 2014 Jun; 106():86-94. PubMed ID: 24713118
[TBL] [Abstract][Full Text] [Related]
12. [Development and Application of An Assay for High-throughput Antiviral Compounds Screening against Alphaviruses].
Wei Y; Li J; Wang H; Cen S; Liang G; Tan W; Zhu W
Bing Du Xue Bao; 2015 Nov; 31(6):641-6. PubMed ID: 26951009
[TBL] [Abstract][Full Text] [Related]
13. Nonstructural Proteins of Alphavirus-Potential Targets for Drug Development.
Abu Bakar F; Ng LFP
Viruses; 2018 Feb; 10(2):. PubMed ID: 29425115
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
